Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 9:57:e12937.
doi: 10.1590/1414-431X2023e12937. eCollection 2024.

Factors associated with non-treatment of hypertension and gender differences at baseline in the ELSA-Brasil cohort

A K M Néri  1   2 , R M F Xavier  3 , S M A Matos  3 , M C C Almeida  4 , R M Ladeira  5 , A A Lopes  6 , D O C Lino  1 , A P P Lázaro  1 , R V B M Cairutas  2 , J H Silva Júnior  2 , J M O Lima  2 , M C Chaves  2 , R P Silva  2 , G B Silva Júnior  1
Affiliations

Factors associated with non-treatment of hypertension and gender differences at baseline in the ELSA-Brasil cohort

A K M Néri et al. Braz J Med Biol Res. .

Abstract

The treatment of arterial hypertension (AH) contributes to the reduction of morbidity and mortality. Gender differences are likely to play a role, as non-treatment is associated with clinical and sociodemographic aspects. The aim of this study was to investigate the factors associated with non-treatment of AH and gender differences in hypertensive individuals from the ELSA-Brasil cohort. The study was conducted with 5,743 baseline hypertensive cohort participants. AH was considered if there was a previous diagnosis or if systolic blood pressure (SBP) was ≥140 and/or diastolic BP (DBP) was ≥90 mmHg. Sociodemographic and anthropometric data, lifestyle, comorbidities, and use of antihypertensive medications were evaluated through interviews and in-person measurements. Treatment with renin-angiotensin-aldosterone system inhibitors (RAASi) or other antihypertensive medications and non-treatment were evaluated with multivariate logistic regression. Non-treatment was observed in 32.8% of hypertensive individuals. Of the 67.7% treated individuals, 41.1% received RAASi. Non-treatment was associated with alcohol consumption in women (OR=1.41; 95%CI: 1.15-1.73; P=0.001), lowest schooling level in men (OR=1.70; 95%CI: 1.32-2.19; P<0.001), and younger age groups in men and women (strongest association in males aged 35-44 years: OR=4.58, 95%CI: 3.17-6.6, P<0.001). Among those using RAASi, a higher proportion of white, older individuals, and with more comorbidities was observed. The high percentage of non-treatment, even in this civil servant population, indicated the need to improve the treatment cascade for AH. Public health policies should consider giving special attention to gender roles in groups at higher risk of non-treatment to reduce inequities related to AH in Brazil.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Criteria used for the study sample selection. GFR: glomerular filtration rate.
Figure 2
Figure 2. Main results of the study comparing hypertensive men and women from the ELSA-Brasil cohort.
See this image and copyright information in PMC

References

    1. Who (World Health Organization) Geneva: WHO; 2020. [Accessed February 22, 2023]. World health statistics 2020: monitoring health for the SDGs, sustainable development goals.https://apps.who.int/iris/handle/10665/332070
    1. NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37–55. doi: 10.1016/S0140-6736(16)31919-5. - DOI - PMC - PubMed
    1. Brasil . Brasília: Ministério da Saúde; 2020. [Accessed February 22, 2023]. Ministério da Saúde. Vigitel Brasil 2019: vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico: estimativas sobre frequência e distribuição sociodemográfica de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2019.https://bvsms.saude.gov.br/bvs/publicacoes/vigitel_brasil_2019_vigilanci...
    1. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:1953–2041. doi: 10.1093/eurheartj/ehy339. - DOI
    1. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International society of hypertension practice guidelines. Hypertension. 2020;75:1334–1357. doi: 10.1161/HYPERTENSIONAHA.120.15026. - DOI - PubMed

Substances